Share This

Related Topics News -

     
 Detail   |   Print 
     
《大行》美銀證券升石藥目標價至5.1元 評級「跑輸大市」
2025-04-28T  
石藥集團新藥SYH2068注射液獲准開展臨床試驗
2025-04-27T  
石藥集團附屬石藥創新第一季轉虧2,690萬人民幣
2025-04-23T  
石藥集團普盧格列汀二甲雙胍緩釋片臨床試驗獲批
2025-04-23T  
石藥集團抗體藥JMT203獲美FDA批准開展臨床研究
2025-04-22T  
石藥集團磷酸奧司他韋乾混懸劑獲藥品註冊批件
2025-04-15T  
石藥抗體偶聯藥物SYS 6041美國臨床試驗獲批
2025-04-14T  
石藥集團SYH2046片獲准開展臨床試驗
2025-04-13T  
石藥集團I類新藥JMT108獲美國臨床試驗批准
2025-04-09T  
《大行》大和降石藥目標價至5元 維持「持有」評級
2025-04-08T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.